NLRP3 and primary progressive multiple sclerosis: Likewise, PBMCs from patients with primary progressive MS (PPMS) overexpress pro-inflammatory cytokines, including IL-1β, IL-6, TNF, and NLRP3, with monocytes being the primary driver of this profile [41].